期刊文献+

乳腺癌髓系来源抑制细胞中吲哚胺2,3-双加氧酶表达与Tregs分布关系及临床意义 被引量:2

Relationship and Clinical Significance between Myeloid Suppressor Cells in Indoleamine 2,3- Expression and Distribution of Tregs Dioxygenase in Breast Cancer
下载PDF
导出
摘要 目的:研究乳腺癌CD33+髓系来源的抑制细胞(MDSCs)中吲哚胺2,3-双加氧酶(IDO)表达情况及与Foxp3+调节性T细胞(Tregs)分布关系和临床意义。方法:运用免疫组化单染技术检测CD33+MDSCs细胞、Foxp3+Tregs,采用免疫组化双染检测CD33+MDSCs细胞中IDO的表达情况。结果:癌组织中CD33+MDSCs细胞、Foxp3+Tregs分布无序,呈散在分布;Foxp3+Tregs高比例组中,CD33+MDSCs细胞中IDO呈高表达,差异有统计学意义(P<0.05);CD33+MDSCs中IDO的表达与患者年龄、肿瘤直径和组织学分级无明显关系,但与是否有淋巴结转移有密切关系(P<0.05)。结论:乳腺癌中CD33+MDSCs中IDO高表达参与肿瘤细胞免疫耐受的形成,可能与乳腺癌淋巴转移存在密切联系。 Objective:To study the expression of indoleamine 2,3-dioxygenase ( IDO) in CD3^3+mye-loid-derived suppressor cells ( MDSCs) and the relationships between the expression of IDO and Foxp^3+reg-ulatory T cells ( Tregs) distribution and clinical significance. Method:Immunohistochemical single staining technique was used to detect CD3^3+MDSCs cells and Foxp3+Tregs.The immunohistochemical double staining was used to detect CD3^3+MDSCs cells indoleamine 2,3-bis dioxygenase (IDO) expression.Result:Carci-noma CD3^3+MDSCs cells, Foxp3+Tregs distribution were disorder and scattered in carcinoma. It showed sig-nificant difference between the expression of MDSCs IDO and Tregs distribution ( P〈0.05). The expression of CD3^3+MDSCs in IDO had no relation with breast cancer , irrespective of age , tumor size and histological grade were coreelated with whether lymph node metastasis (P〈0.05).Conclusion:It showed a close contact between carcinoma CD 33+MDSCs IDO expression in tumor cells and the formation of immune tolerance. Carcinoma CD3^3+MDSCs IDO expression may be associated with the presence of lymph node metastasis.
出处 《河北医学》 CAS 2015年第1期134-137,共4页 Hebei Medicine
基金 甘肃省卫生厅科研基金 (编号:2012D59)
关键词 乳腺癌 吲哚胺2 3-双加氧酶 免疫耐受 CD3^3+MDSCs Foxp^3+Tregs Breast cancer Indoleamine 2,3-dioxygenase Immune tolerance CD3^3+ MDSCs Foxp^3+ Tregs
  • 相关文献

参考文献9

  • 1Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity' s roles in cancer suppression and pro- motion[J]. Science, 2011, 331(6024): 1565-1570.
  • 2余宗林,李中琴.乳腺癌微转移的检测及临床意义[J].临床和实验医学杂志,2009,8(1):134-136. 被引量:8
  • 3陆作洁.首发为血液系统表现的骨髓转移癌39例分析[J].检验医学与临床,2013,10(7):841-842. 被引量:3
  • 4Movahedi K, Guilliams M, Van den Bossche J, et al. Iden- tification of discrete tumor-induced myeloid- derived sup- pressor cell subpopulations with distinct T cell-suppressive activity [ J ]. Blood, 2008,111 (8) :4233-4244.
  • 5Jessiea B. Katz, Alexander J. Muller, GeorgeC. Prendergast In- doleamine 2, 3- dioxygenasein Teell toleranee and tumoral immunee sea[ J] .Immunologieal Reviews,2008, (222) : 206 -221.
  • 6Baban B, Chandler PR, Sharma MD, et al. IDO activates regulatory T ceils and blocks their conversion into Th17-like T cells[J]. Immunol, 2009, 183(4): 2475-2483.
  • 7Godin-Ethier J, Hanafi LA, Piccirillo CA, et al. Indoleam- ine 2,3-dioxygenase expression in human cancers: clinical and immunologic perspectives [ J ]. Clin Cancer Res, 2011, 17(22) : 6985-6991.
  • 8杜华劲,张月君,周彩云.Ki-67和p53在三阴性乳腺癌中的表达和意义[J].中华全科医学,2013,11(9):1393-1395. 被引量:12
  • 9Kusmartsev S, Su Z, Heiser A, et al. Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma[ J].Clin Cancer Res, 2008, 14(24): 8270-8278.

二级参考文献33

共引文献20

同被引文献18

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部